Blockade of deubiquitinase YOD1 degrades oncogenic PML/RAR α and eradicates acute promyelocytic leukemia cells.

MLA

Shao, Xuejing, et al. “Blockade of Deubiquitinase YOD1 Degrades Oncogenic PML/RAR α and Eradicates Acute Promyelocytic Leukemia Cells.” Acta Pharmaceutica Sinica. B, vol. 12, no. 4, Apr. 2022, pp. 1856–70. EBSCOhost, https://doi.org/10.1016/j.apsb.2021.10.020.

APA

Shao, X., Chen, Y., Wang, W., Du, W., Zhang, X., Cai, M., Bing, S., Cao, J., Xu, X., Yang, B., He, Q., & Ying, M. (2022). Blockade of deubiquitinase YOD1 degrades oncogenic PML/RAR α and eradicates acute promyelocytic leukemia cells. Acta Pharmaceutica Sinica. B, 12(4), 1856–1870. https://doi.org/10.1016/j.apsb.2021.10.020

Chicago

Shao, Xuejing, Yingqian Chen, Wei Wang, Wenxin Du, Xingya Zhang, Minyi Cai, Shaowei Bing, et al. 2022. “Blockade of Deubiquitinase YOD1 Degrades Oncogenic PML/RAR α and Eradicates Acute Promyelocytic Leukemia Cells.” Acta Pharmaceutica Sinica. B 12 (4): 1856–70. doi:10.1016/j.apsb.2021.10.020.